PASADENA, CA, USA I February 25, 2025 I Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback